Ian Stansfield

1.0k total citations
23 papers, 745 citations indexed

About

Ian Stansfield is a scholar working on Molecular Biology, Hepatology and Organic Chemistry. According to data from OpenAlex, Ian Stansfield has authored 23 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Hepatology and 6 papers in Organic Chemistry. Recurrent topics in Ian Stansfield's work include Hepatitis C virus research (9 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Biochemical and Molecular Research (5 papers). Ian Stansfield is often cited by papers focused on Hepatitis C virus research (9 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Biochemical and Molecular Research (5 papers). Ian Stansfield collaborates with scholars based in United Kingdom, Italy and United States. Ian Stansfield's co-authors include Michael Rowley, Frank Narjes, Nadia Gennari, Immacolata Conte, Giovanni Migliaccio, Paul D. Leeson, Uwe Koch, Graeme I. Stevenson, Colin H. Macphee and Stephen A. Smith and has published in prestigious journals such as Journal of Virology, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Ian Stansfield

23 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Stansfield United Kingdom 15 272 256 203 195 177 23 745
Denis R. St. Laurent United States 17 216 0.8× 248 1.0× 311 1.5× 166 0.9× 154 0.9× 27 768
Robert G. Gentles United States 17 345 1.3× 100 0.4× 221 1.1× 146 0.7× 86 0.5× 36 669
Anne Cooper United Kingdom 13 155 0.6× 168 0.7× 67 0.3× 169 0.9× 21 0.1× 20 724
Scott Martin United Kingdom 15 407 1.5× 191 0.7× 254 1.3× 142 0.7× 96 0.5× 32 955
Richard A. Nugent United States 15 289 1.1× 69 0.3× 356 1.8× 60 0.3× 80 0.5× 26 897
Daniel Vitt Germany 20 435 1.6× 45 0.2× 168 0.8× 205 1.1× 84 0.5× 45 906
John K. Pratt United States 15 207 0.8× 186 0.7× 311 1.5× 103 0.5× 134 0.8× 23 711
John J. Piwinski United States 21 538 2.0× 65 0.3× 565 2.8× 44 0.2× 68 0.4× 49 1.1k
Anja Sandström Sweden 17 296 1.1× 153 0.6× 351 1.7× 56 0.3× 118 0.7× 52 756
Alessandro Deplano Italy 16 203 0.7× 270 1.1× 192 0.9× 223 1.1× 20 0.1× 31 709

Countries citing papers authored by Ian Stansfield

Since Specialization
Citations

This map shows the geographic impact of Ian Stansfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Stansfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Stansfield more than expected).

Fields of papers citing papers by Ian Stansfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Stansfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Stansfield. The network helps show where Ian Stansfield may publish in the future.

Co-authorship network of co-authors of Ian Stansfield

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Stansfield. A scholar is included among the top collaborators of Ian Stansfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Stansfield. Ian Stansfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holmes, Ian P., Olivier Lorthioir, Andrew H. Payne, et al.. (2010). The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure. Bioorganic & Medicinal Chemistry Letters. 20(6). 2013–2016. 5 indexed citations
2.
Conte, Immacolata, Claudio Giuliano, Frank Narjes, et al.. (2009). Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture. Bioorganic & Medicinal Chemistry Letters. 19(6). 1779–1783. 26 indexed citations
3.
Stansfield, Ian, Angela Mackay, Immacolata Conte, et al.. (2008). Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase. Bioorganic & Medicinal Chemistry Letters. 19(3). 627–632. 38 indexed citations
4.
Stansfield, Ian, Immacolata Conte, Giovanni Migliaccio, et al.. (2007). Development of carboxylic acid replacements in indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 17(18). 5143–5149. 25 indexed citations
5.
Ontoria, Jesus M., José Ignacio Martı́n Hernando, Savina Malancona, et al.. (2006). Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 16(15). 4026–4030. 33 indexed citations
6.
Giuliano, Claudio, et al.. (2005). Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides. Letters in Drug Design & Discovery. 2(6). 456–461. 3 indexed citations
7.
Stansfield, Ian, Stefania Colarusso, Nadia Gennari, et al.. (2004). Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid. Bioorganic & Medicinal Chemistry Letters. 14(20). 5085–5088. 31 indexed citations
8.
Malancona, Savina, Stefania Colarusso, Jesus M. Ontoria, et al.. (2004). SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease. Bioorganic & Medicinal Chemistry Letters. 14(17). 4575–4579. 20 indexed citations
9.
Tomei, Licia, Sergio Altamura, Linda Bartholomew, et al.. (2003). Mechanismof Action and Antiviral Activity of Benzimidazole-Based AllostericInhibitors of the Hepatitis C Virus RNA-Dependent RNAPolymerase. Journal of Virology. 77(24). 13225–13231. 160 indexed citations
10.
Bloomer, Jackie C., Murray J. B. Brown, Hung‐Yuan Cheng, et al.. (2003). The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 13(6). 1067–1070. 100 indexed citations
11.
Colarusso, Stefania, Benjamin Gerlach, Uwe Koch, et al.. (2002). Evolution, synthesis and SAR of tripeptide α-ketoacid Inhibitors of the hepatitis C virus NS3/NS4A serine protease. Bioorganic & Medicinal Chemistry Letters. 12(4). 705–708. 40 indexed citations
12.
Boyd, Helen, Deirdre M. B. Hickey, Robert J. Ife, et al.. (2002). Potent, orally active inhibitors of lipoprotein-associated phospholipase A2: 1-(biphenylmethylamidoalkyl)-pyrimidones. Bioorganic & Medicinal Chemistry Letters. 12(1). 51–55. 25 indexed citations
13.
Bloomer, Jackie C., Murray J. B. Brown, Hung‐Yuan Cheng, et al.. (2002). The discovery of SB-435495. Bioorganic & Medicinal Chemistry Letters. 12(18). 2603–2606. 34 indexed citations
14.
Boyd, Helen, Beverley Hammond, Robert J. Ife, et al.. (2001). The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 11(5). 701–704. 8 indexed citations
15.
Bloomer, Jackie C., Helen Boyd, Robert J. Ife, et al.. (2001). 1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A 2. Bioorganic & Medicinal Chemistry Letters. 11(14). 1925–1929. 13 indexed citations
16.
Boyd, Helen, Deirdre M. B. Hickey, Robert J. Ife, et al.. (2000). N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 10(22). 2557–2561. 24 indexed citations
17.
Boyd, Helen, Robert J. Ife, Colin A. Leach, et al.. (2000). 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2. Bioorganic & Medicinal Chemistry Letters. 10(4). 395–398. 17 indexed citations
18.
19.
Rowley, Michael, Paul D. Leeson, Graeme I. Stevenson, et al.. (1993). 3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex. Journal of Medicinal Chemistry. 36(22). 3386–3396. 81 indexed citations
20.
Stevenson, Graeme I., Paul D. Leeson, Michael Rowley, Ian R. Sanderson, & Ian Stansfield. (1992). Synthesis of cis and trans 4-amido 2-carboxytetrahydroquinolines, high affinity ligands at the glycine site of the NMDA receptor. Bioorganic & Medicinal Chemistry Letters. 2(5). 371–374. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denis R. St. Laurent Breakdown of academic impact, for papers by Robert G. Gentles Breakdown of academic impact, for papers by Anne Cooper Breakdown of academic impact, for papers by Scott Martin Breakdown of academic impact, for papers by Richard A. Nugent Breakdown of academic impact, for papers by Daniel Vitt Breakdown of academic impact, for papers by John K. Pratt Breakdown of academic impact, for papers by John J. Piwinski Breakdown of academic impact, for papers by Anja Sandström Breakdown of academic impact, for papers by Alessandro Deplano
Rankless by CCL
2026